$19.23
1.216.69%
In chiusura: -
$19.88
0.653.39%
After hour: 7:53 PM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Viridian Therapeutics Inc (NASDAQ:VRDN) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 11.64M a 11.68M. Questo rappresenta il 14.93% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Viridian Therapeutics Corp (XNAS:VRDN) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 626.18K azioni scambiate al giorno, ci vorrebbero 18.65 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
11.68M
Vendite allo scoperto %
14.9%
Giorni di copertura
18.65
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
VRDN | Viridian Therapeutics, Inc. Co | 07/31/2025 | 08/11/2025 | 14.93% | 78,183,005 | 11,675,434 | 626,183 | 18.65 | |
VRDN | Viridian Therapeutics, Inc. Co | 07/15/2025 | 07/24/2025 | 14.90% | 78,112,662 | 11,639,358 | 748,924 | 15.54 | |
VRDN | Viridian Therapeutics, Inc. Co | 06/30/2025 | 07/10/2025 | 13.80% | 78,112,662 | 10,778,607 | 744,992 | 14.47 | |
VRDN | Viridian Therapeutics, Inc. Co | 06/13/2025 | 06/25/2025 | 14.51% | 78,112,662 | 11,335,016 | 711,127 | 15.94 | |
VRDN | Viridian Therapeutics, Inc. Co | 05/30/2025 | 06/10/2025 | 13.70% | 78,112,662 | 10,702,697 | 809,546 | 13.22 | |
VRDN | Viridian Therapeutics, Inc. Co | 05/15/2025 | 05/27/2025 | 13.50% | 78,112,662 | 10,546,849 | 826,055 | 12.77 | |
VRDN | Viridian Therapeutics, Inc. Co | 04/30/2025 | 05/09/2025 | 12.96% | 78,112,662 | 10,124,402 | 774,040 | 13.08 | |
VRDN | Viridian Therapeutics, Inc. Co | 04/15/2025 | 04/25/2025 | 15.84% | 69,738,716 | 11,043,451 | 1,286,349 | 8.59 | |
VRDN | Viridian Therapeutics, Inc. Co | 03/31/2025 | 04/09/2025 | 14.57% | 69,738,716 | 10,159,066 | 762,190 | 13.33 | |
VRDN | Viridian Therapeutics, Inc. Co | 03/14/2025 | 03/25/2025 | 14.34% | 69,738,716 | 9,998,425 | 829,414 | 12.05 | |
VRDN | Viridian Therapeutics, Inc. Co | 02/28/2025 | 03/11/2025 | 13.72% | 69,738,716 | 9,567,139 | 889,478 | 10.76 | |
VRDN | Viridian Therapeutics, Inc. Co | 02/14/2025 | 02/26/2025 | 13.97% | 69,738,716 | 9,740,752 | 1,016,261 | 9.58 | |
VRDN | Viridian Therapeutics, Inc. Co | 01/31/2025 | 02/11/2025 | 15.60% | 69,738,716 | 10,881,666 | 924,699 | 11.77 | |
VRDN | Viridian Therapeutics, Inc. Co | 01/15/2025 | 01/27/2025 | 16.68% | 69,738,716 | 11,634,941 | 1,596,461 | 7.29 | |
VRDN | Viridian Therapeutics, Inc. Co | 12/31/2024 | 01/10/2025 | 17.28% | 69,738,716 | 12,050,989 | 2,249,757 | 5.36 | |
VRDN | Viridian Therapeutics, Inc. Co | 12/13/2024 | 12/24/2024 | 13.41% | 69,738,716 | 9,353,713 | 1,076,166 | 8.69 | |
VRDN | Viridian Therapeutics, Inc. Co | 11/29/2024 | 12/10/2024 | 12.55% | 69,738,716 | 8,750,391 | 999,985 | 8.75 | |
VRDN | Viridian Therapeutics, Inc. Co | 11/15/2024 | 11/26/2024 | 13.04% | 69,738,716 | 9,097,352 | 1,386,669 | 6.56 | |
VRDN | Viridian Therapeutics, Inc. Co | 10/31/2024 | 11/11/2024 | 14.98% | 66,882,489 | 10,020,094 | 711,394 | 14.09 | |
VRDN | Viridian Therapeutics, Inc. Co | 10/15/2024 | 10/24/2024 | 14.64% | 66,882,489 | 9,791,768 | 872,025 | 11.23 | |
VRDN | Viridian Therapeutics, Inc. Co | 09/30/2024 | 10/09/2024 | 15.18% | 66,882,489 | 10,151,921 | 1,588,378 | 6.39 | |
VRDN | Viridian Therapeutics, Inc. Co | 09/13/2024 | 09/24/2024 | 15.64% | 66,882,489 | 10,461,877 | 4,077,044 | 2.57 | |
VRDN | Viridian Therapeutics, Inc. Co | 08/30/2024 | 09/11/2024 | 14.76% | 54,415,889 | 8,034,096 | 661,569 | 12.14 | |
VRDN | Viridian Therapeutics, Inc. Co | 07/31/2024 | 08/09/2024 | 15.60% | 54,415,889 | 8,488,252 | 1,215,924 | 6.98 | |
VRDN | Viridian Therapeutics, Inc. Co | 07/15/2024 | 07/24/2024 | 15.88% | 54,348,437 | 8,628,652 | 767,488 | 11.24 | |
VRDN | Viridian Therapeutics, Inc. Co | 06/28/2024 | 07/10/2024 | 14.57% | 54,348,437 | 7,915,953 | 1,535,089 | 5.16 | |
VRDN | Viridian Therapeutics, Inc. Co | 06/14/2024 | 06/26/2024 | 17.28% | 54,348,437 | 9,393,665 | 1,014,339 | 9.26 | |
VRDN | Viridian Therapeutics, Inc. Co | 05/31/2024 | 06/11/2024 | 17.76% | 54,348,437 | 9,653,001 | 922,965 | 10.46 | |
VRDN | Viridian Therapeutics, Inc. Co | 05/15/2024 | 05/24/2024 | 18.03% | 54,348,437 | 9,801,493 | 845,236 | 11.6 | |
VRDN | Viridian Therapeutics, Inc. Co | 04/30/2024 | 05/09/2024 | 17.14% | 54,348,437 | 9,313,837 | 806,256 | 11.55 | |
VRDN | Viridian Therapeutics, Inc. Co | 04/15/2024 | 04/24/2024 | 17.90% | 54,348,437 | 9,726,768 | 711,893 | 13.66 | |
VRDN | Viridian Therapeutics, Inc. Co | 03/28/2024 | 04/09/2024 | 15.43% | 61,388,447 | 9,471,425 | 1,012,103 | 9.36 | |
VRDN | Viridian Therapeutics, Inc. Co | 03/15/2024 | 03/26/2024 | 12.41% | 61,388,447 | 7,619,785 | 1,152,713 | 6.61 | |
VRDN | Viridian Therapeutics, Inc. Co | 02/29/2024 | 03/11/2024 | 12.34% | 61,388,447 | 7,574,402 | 864,810 | 8.76 | |
VRDN | Viridian Therapeutics, Inc. Co | 01/31/2024 | 02/09/2024 | 14.44% | 58,349,774 | 8,422,799 | 1,004,261 | 8.39 | |
VRDN | Viridian Therapeutics, Inc. Co | 01/12/2024 | 01/24/2024 | 13.89% | 58,349,774 | 8,101,927 | 917,985 | 8.83 | |
VRDN | Viridian Therapeutics, Inc. Co | 12/29/2023 | 01/10/2024 | 16.90% | 51,206,916 | 8,653,608 | 1,026,572 | 8.43 | |
VRDN | Viridian Therapeutics, Inc. Co | 12/15/2023 | 12/27/2023 | 16.52% | 51,206,916 | 8,459,462 | 948,237 | 8.92 | |
VRDN | Viridian Therapeutics, Inc. Co | 11/30/2023 | 12/11/2023 | 16.60% | 51,206,916 | 8,501,483 | 695,914 | 12.22 | |
VRDN | Viridian Therapeutics, Inc. Co | 11/15/2023 | 11/27/2023 | 16.18% | 51,206,916 | 8,283,023 | 928,521 | 8.92 | |
VRDN | Viridian Therapeutics, Inc. Co | 10/31/2023 | 11/09/2023 | 19.30% | 42,291,034 | 8,161,368 | 886,039 | 9.21 | |
VRDN | Viridian Therapeutics, Inc. Co | 10/13/2023 | 10/24/2023 | 18.06% | 42,291,034 | 7,637,936 | 866,029 | 8.82 | |
VRDN | Viridian Therapeutics, Inc. Co | 09/29/2023 | 10/10/2023 | 22.31% | 42,291,034 | 9,436,491 | 435,176 | 21.68 | |
VRDN | Viridian Therapeutics, Inc. Co | 09/15/2023 | 09/26/2023 | 22.09% | 42,291,034 | 9,342,250 | 795,756 | 11.74 | |
VRDN | Viridian Therapeutics, Inc. Co | 08/31/2023 | 09/12/2023 | 22.37% | 42,291,034 | 9,458,462 | 388,507 | 24.35 | |
VRDN | Viridian Therapeutics, Inc. Co | 08/15/2023 | 08/24/2023 | 20.47% | 42,291,034 | 8,658,557 | 639,374 | 13.54 |
In cerca di azioni più vendute allo scoperto?